This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-4290v1 69/8/3374    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, L. Articles by Karpatkin, S. Search for Related Content PubMed PubMed Citation Articles by Hu, L. Articles by Karpatkin, S.

Thrombin Induces Tumor Cell Cycle Activation and Spontaneous Growth by Down-regulation of p27^Kip1, in Association with the Up-regulation of Skp2 and MiR-222

Departments of ¹ Medicine and ² Pathology, New York University School of Medicine, New York, New York

Requests for reprints: Simon Karpatkin, New York University Medical Center, 550 First Avenue, New York, NY 10016. Phone: 212-263-5609; Fax: 212-263-0695; E-mail: Simon.Karpatkin{at}med.nyu.edu.

Key Words: thrombin • cell cycle • p27^Kip1 • Skp2 • MiR-222 • TRAMP

The effect of thrombin on tumor cell cycle activation and spontaneous growth was examined in synchronized serum-starved tumor cell lines and a model of spontaneous prostate cancer development in TRAMP mice. BrdUrd incorporation and propidium iodide staining of prostate LNCaP cells arrested in G₀ and treated with thrombin or serum revealed a 48- and 29-fold increase in S phase cells, respectively, at 8 hours. Similar results were obtained with TRAMP cells and a glioblastoma cell line, T98G. Cell cycle kinases and inhibitors in synchronized tumor cells revealed high levels of p27^Kip1 and low levels of Skp2 and cyclins D1 and A. Addition of thrombin, TFLLRN, or serum down-regulated p27^Kip1 with concomitant induction of Skp2, Cyclin D1, and Cyclin A with similar kinetics. LNCaP p27^Kip1-transfected cells or Skp2 knockdown cells were refractory to thrombin-induced cell cycle activation. MicroRNA 222, an inhibitor of p27^Kip1, was robustly up-regulated by thrombin. The in vitro observations were tested in vivo with transgenic TRAMP mice. Repetitive thrombin injection enhanced prostate tumor volume 6- to 8-fold (P < 0.04). Repetitive hirudin, a specific potent antithrombin, decreased tumor volume 13- to 24-fold (P < 0.04). Thus, thrombin stimulates tumor cell growth in vivo by down-regulation of p27^Kip1. [Cancer Res 2009;69(8):3374–81]

This article has been cited by other articles:

				X. LIU, J. YU, L. JIANG, A. WANG, F. SHI, H. YE, and X. ZHOU MicroRNA-222 Regulates Cell Invasion by Targeting Matrix Metalloproteinase 1 (MMP1) and Manganese Superoxide Dismutase 2 (SOD2) in Tongue Squamous Cell Carcinoma Cell Lines Cancer Genomics Proteomics, May 1, 2009; 6(3): 131 - 139. [Abstract] [Full Text] [PDF]